Quiz 3 Non-diabetes endocrine and supplements Flashcards

1
Q

Cholecalciferol Brand Name

A

Vitamin D3, Adrovance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cholecalciferol Class

A

Vitamin D analogs (Nutriceutical Nutritive Agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cholecalciferol Indications

A

Vitamin D deficiency
Refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cholecalciferol General Mechanism of Action

A

Vitamin D3 regulates both the calcium and phosphate as well as citric acid metabolism, promotes the intestinal absorption of calcium and controls the incorporation of calcium into the organic bone matrix [13]. Vitamin D mediates intestinal calcium absorption by an active transport mechanism and also promotes normal bone formation [14].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cholecalciferol Pregnancy Category

A

Fetal risk cannot be ruled out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cholecalciferol Contraindications

A

Hypersensitivity, Hypercalcemia, Hypervitaminosis D, Hyperlipidemia, Hyperphosphatemia, Liver disease, renal impairment, renal osteodystrophy, sarcoidosis, arteriosclerosis, cardiac conditions, concurrent use of calcium-containing preparations, other vitamin D-containing preparations or vitaman D analogs, or thiazide diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholecalciferol Black Box Warning

A

N/A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cholecalciferol Key Counseling Points

A

Warn patient to report symptoms of hypercalcemia. Side effects with excessive use may include nausea, anorexia, weight loss, constipation, polyuria, polydispsia, hypertension, weakness, and muscle aches or stiffness. Instruct patient to maintain adequate intake of calcium with drug. Avoid additional vitamin D supplements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Calcium; Cholecalciferol Class

A

Antacid, calcium containing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Calcium; Cholecalciferol Indication

A

Vitamin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Calcium; Cholecalciferol Pregnancy Category

A

NONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Calcium; Cholecalciferol Contraindication

A
  • Hypercalcemia
  • Hypervitaminosis D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Calcium; Cholecalciferol Black Box Warning

A

NONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Calcium; Cholecalciferol Counseling

A
  • Overdose symptoms may include nausea, loss of appetite, thirst, urinating more or less than usual, body aches, stiffness, confusion, or irregular heartbeats.
  • Ask a doctor or pharmacist before taking any multivitamins, mineral supplements, or antacids while you are taking cholecalciferol.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cyanocobalamin Brand Name

A

Cobolin-M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cyanocobalamin Class

A

Essential B Vitamin (B12)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cyanocobalamin Indications

A

Cobalamin deficiency, normal absorption //
Cobalamin deficiency, malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cyanocobalamin MoA

A

B12 is required for the synthesis of the amino acid methionine from homocysteine. A deficiency of B12 results in hyperhomocysteinemia and a decrease in methionine. Since methionine is required for DNA synthesis, B12 deficiency also results in decreased DNA synthesis, which presents clinically as macrocytic anemia when red blood cells are unable to extrude their nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cyanocobalamin Pregnancy Category

A

Pregnancy Compatible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cyanocobalamin Contraindication

A

Hypersensitivity to cyanocobalamin or colbat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cyanocobalamin Black Box Warning

A

N/A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cyanocobalamin Key Counseling Points

A

May require several weeks for maximum effect. Take extended-release products with food. Avoid alcohol as it inhibits the absorption of B12.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ergocalciferol Brand Name

A

Drisdol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ergocalciferol Class

A

Vitamins, Fat-Soluble. Vitiman D analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Ergocalciferol Indications

A
  1. hypoparathyroidism
  2. Refractory rickets (vitaman D resistant rickets)
  3. familial hypophosphatemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Ergocalciferol MoA

A

After the activation of the vitamin D receptor, some of the biological changes produced by ergocalciferol include mobilization and accretion of calcium and phosphorus in the bone, absorption of calcium and phosphorus in the intestine, and reabsorption of calcium and phosphorus in the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Ergocalciferol Contraindications

A

Hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Ergocalciferol Black Box Warning

A

N/A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Ergocalciferol Counseling Points

A

Take by mouth as directed. Best absorbed when taken after a meal, but may be taken with or without food. If using liquid form of this medication, measure the dose using a special measuring device/spoon. Certain medications (bile acid sequestriants) can decrease the absorption of Vitamin D. Take your doses of these medications as far as possible from your doses of Vitaman D - at least 2 hours if possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Estradiol Brand Name

A

Estrace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Estradiol Class

A

Estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Estradiol Indication

A
  1. Abnormal vasomotor function (moderate to severe)
  2. Atrophic vulva or vagina (moderate to severe), menopause
  3. Breast cancer, metastatic for palliation only
  4. Carcinoma of prostate, advanced, androgen-dependent, for palliation only
  5. Decreased estrogen level, secondary to hypogonadism, castration or primary ovarian failutre
  6. Postmenopausal osteoporosis, prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Estradiol MoA

A

Estradiol (17β-estradiol; E2) is the most potent of the naturally occurring estrogens and the major estrogen secreted during the reproductive years. Estradiol and other estrogens produce characteristic effects on specific tissues (such as breast), cause proliferation of vaginal and uterine mucosa, increase calcium deposition in bone, and accelerate epiphyseal closure after initial growth stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Estradiol Pregnancy Category

A

Contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Estradiol Contraindication

A

Hypersensitivity to estradiol; history of thromboembolic disorders, breast cancer, any estrogen-dependent neoplasm, known or suspected pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Estradiol Black Box Warning

A

Endometrial and breast cancer risk, dementia risk; should not be used to reduce CV risk; secondary exposure risk (transdermal solution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Estradiol Counseling Points

A

Report abnormal vaginal bleeding or signs/symptoms of a thromboembolic disorder. Do not smoke during therapy, as this increases the risk of thromboembolic events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Ethinyl Estradiol; Desogestrel Class

A

Contraceptive, Estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Ethinyl Estradiol; Desogestrel Indication

A
  1. Contraception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Ethinyl Estradiol; Desogestrel MoA

A

The contraceptive effect of desogestrel/ethinyl estradiol is based on interaction of various factors, the most important of which is ovulation inhibition and changes in cervical secretion [467]. Desogestrel/ethinyl estradiol is a combination of oral contraceptives that acts by suppressing gonadotropins. This activity leads to inhibition of ovulation, changes in cervical mucus and endometrium, thus, preventing fertilization and implantation [3]. Ethinyl estradiol is a well-known synthetic estrogen. Desogestrel is a synthetic progestogen. After oral administration it has a strong ovulation-inhibiting activity, a strong progestational and anti-estrogenic activity, no estrogenic activity, very weak androgenic/anabolic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Ethinyl Estradiol; Desogestrel Pregnancy Category

A

Contraindicated (I would hope so)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Ethinyl Estradiol; Desogestrel Contraindication

A

Blood pressure 160mm Hg or greater systolic or 100 mmHg or greater diastolic, persistent. Carcinoma of the breast, known or suspected, or personal history. Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia. Cerebral vascular or coronary artery disease, current or history.Cholestatic jaundice of pregnancy or jaundice with prior hormonal contraceptive use.Concomitant hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir. Deep vein thrombophlebitis or thromboembolic disorders, past history. Diabetes with vascular involvement. Genital bleeding, undiagnosed abnormal. Headaches with focal neurological symptoms. Smoke, if over age 35. Heavy cigarette smoking. Hepatic adenomas or carcinomas or active liver disease. Hepatocellular disease with abnormal liver function. Hypersensitivity to any component of these products. Hypertension, severe. Major surgery with prolonged immobilization. pregnancy, known or suspected. Thrombophlebitis, valvular heart disease. inherited or acquired hypercoagulopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Ethinyl Estradiol; Desogestrel Black Box Warning

A

Oral: Smoking is not advised in women using oral contraceptives. Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age

Tablet: Ortho-Cept(R): Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and with the number of cigarettes smoked and is quite marked in women over 35 years of age. Use of combination oral contraceptives is not recommended in women who are over 35 years of age that smoke [5].
Velivet(TM): Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke [9].
Desogen(R): Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age, and smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Ethinyl Estradiol; Desogestrel Key Counseling Points

A

Report upcoming elective surgeries, prolonged periods of immunocilization, or recent childbirth as this may increase the risk of blod clots. Side effects may include nausea, vomiting, breakthrough bleeding, weight gain, breast tenderness, headache, and migraine. Caution patient to report symptoms of blood clots, liver tumors, or high blood pressure. Report persistent bleeding. Counsel patient to report changes in vision or difficulty with contact lens wear. Advise patient to report symptoms of fluid retention. Take drug at the same time every day and do not allow mroe than 24 hours between doses. Use a non-hormonal backup form of contraception for the first 7 days. Do not smoke during baby .Encourage to patient not smoke during therapy. Instruct patient that if a single active dose is missed take the tablet as soon as possible and resume a normal schedule. If more than one active dose is missed, contact a physician for instructions. Use of additional nonhormonal methods of contraception may be necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Ethinyl Estradiol; Drospirenone Class

A

Contraceptive, Contraceptive combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Ethinyl Estradiol; Drospirenone Indication

A
  1. Acne (Moderate) - contraception
  2. Contraception
  3. Contraception - Premenstrual dysphoric disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Ethinyl Estradiol; Drospirenone MoA

A

The contraceptive effect of drospirenone/ethinyl estradiol is based on interaction of various factors, the most important of which is ovulation inhibition and changes in the endometrium [485]. Drospirenone/ethinyl estradiol is an combination oral contraceptive (COC) that works primarily by suppressing ovulation. Additionally, COC agents cause cervical mucus changes that block sperm penetration and endometrial changes that reduce the chance of implantation [482][483]. Although the exact mechanism of action in acne is unknown, drospirenone and ethinyl estradiol increase sex hormone binding globulin and decrease free testosterone, which may play a role

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Ethinyl Estradiol; Drospirenone Pregnancy

A

Contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Ethinyl Estradiol; Drospirenone Contraindication

A

A) Adrenal insufficiency
B) Breast cancer or other estrogen or progestin-sensitive cancer, current or past history
C) Cerebrovascular disease
D) Concomitant use with hepatitis C drug combinations containing ombitasvir, paritaprevir/ritonavir, with or without dasabuvir
E) Coronary artery disease
F) Deep vein thrombosis or pulmonary embolism, current or past history
G) Diabetes mellitus with vascular disease
H) Headaches with focal neurological symptoms or migraine headaches with or without aura if over age 35 years
I) Hepatic dysfunction
J) Hepatic tumors, benign or malignant
K) Hypercoagulopathies, inherited or acquired
L) Hypertension, uncontrolled
M) Pregnancy
N) Renal insufficiency
O) Smoking and over age 35 years
P) Thrombogenic valvular or thrombogenic rhythm diseases of the heart (eg, subacute bacterial endocarditis with valvular disease or atrial fibrillation)
Q) Uterine bleeding, undiagnosed, abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Ethinyl Estradiol; Drospirenone Black Box Warning

A

Cigarette Smoking and Serious Cardiovascular Events
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs should not be used by women who are over 35 years of age and smoke [6][7].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Ethinyl Estradiol; Drospirenone Counseling

A

Patients over 35 years of age should not smoke during therapy, as this increases the risk of serious cardiovascular side effects. [6][7]
Advise patient to practice safe sex. Drug does not prevent disease transmission. [6][7]
Discuss potential long-term adverse effects of hormone therapy including myocardial infarction, stroke, thrombophlebitis, dementia, venous thromboembolism (VTE), pulmonary embolism, and breast cancer. Inform patient that risk of VTE is greatest after initially starting therapy or restarting therapy after a 4-week or greater pill-free interval. [6][7]
Drug may cause premenstrual syndrome, headache/migraine, breast pain/tenderness/discomfort, nausea/vomiting, fatigue, abdominal pain/tenderness/discomfort, weight gain, and mood changes. [6][7]
Instruct patient to report signs/symptoms of serious cardiovascular events, such as myocardial infarction, stroke, and arterial or venous thrombosis. [6][7]
Patient should report new headaches that are persistent, severe, or recurrent, abnormal vaginal bleeding, amenorrhea of 2 or more consecutive cycles, or jaundice. [6][7]
Patients should report any unexplained partial or complete loss of vision. In addition, patients who wear contact lenses should report visual changes or changes in lens tolerance. [6][7]
This drug should be taken every day, at the same time each day, in the exact order noted on the packaging. [6][7]
Advise patient to use a nonhormonal back-up form of contraception for the first 7 days if a Sunday-start regimen is initiated or if drug is started postpartum but before menstruation resumes. [6][7]
Advise patient that certain drugs may cause oral contraceptives to be less effective and backup contraception may be necessary. Consult healthcare professional prior to new drug use. [6][7]
Review with the patient the procedure for handling missed doses. It is very important that the patient follow carefully missed-dose instructions for the particular brand or formulation prescribed in order to prevent pregnancy. [6][7]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Ethinyl Estradiol; Levonorgestrel Class

A

Contraceptive, Contraceptive combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Ethinyl Estradiol; Levonorgestrel Indication

A
  1. Contraception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Ethinyl Estradiol; Levonorgestrel MoA

A

Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which reduce the likelihood of implantation) [480][481].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Ethinyl Estradiol; Levonorgestrel Pregnancy Category

A

Contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Ethinyl Estradiol; Levonorgestrel Contraindication

A

A) Acute viral hepatitis, or severe (decompensated) cirrhosis [6]
B) BMI greater than or equal to 30 kg/m(2)
C) Carcinoma of the breast, known, suspected, or personal history
D) Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia
or progestin-sensitive cancer, current or past
E) Cerebrovascular or coronary artery disease, current or past history
F) Cholestatic jaundice of pregnancy or jaundice with prior pill use
G) Concomitant hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir
H) Deep vein thrombophlebitis or thromboembolic disorders (eg, pulmonary embolism), current or history of
I) Diabetes with vascular disease
J) Diabetes mellitus and are over age 35, diabetes mellitus with hypertension or other end-organ damage, or diabetes mellitus of greater than 20 years duration
K) Genital bleeding, undiagnosed, abnormal
L) Headaches with focal neurological symptoms
M) Hepatic adenomas or carcinomas or other liver tumors, benign or malignant
N) Hypersensitivity to any of the product components
O) Liver disease, active
P) Major surgery with prolonged immobilization
Q) Migraines with aura
R) Migraines with or without aura and older than 35 years
S) Pregnancy, known or suspected Smoking and older than 35 years
U) Thrombogenic rhythm disorders
V) Thrombophilias, hereditary or acquired
W) Thrombophlebitis or thromboembolic disorders
X) Uncontrolled hypertension or hypertension with vascular disease
Y) Undiagnosed abnormal uterine bleeding
Z) Valvular heart disease with thrombogenic complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Ethinyl Estradiol; Levonorgestrel Black Box Warning

A

Oral (Tablet)
a) Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women older than 35 years, and with the number of cigarettes smoked. Women who use oral contraceptives should be strongly advised not to smoke

2) Transdermal (Patch, Extended Release)
a) Warning: Cigarette Smoking and Serious Cardiovascular Events and Contraindicated in Women with BMI greater than or equal to 30 kg/m(2)
Cigarette Smoking and Serious Cardiovascular Events
Cigarette smoking increases the risk of serious cardiovascular events from combined hormonal contraceptive (CHC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, CHCs, including levonorgestrel/ethinyl estradiol, are contraindicated in women who are over 35 years of age and smoke.

Contraindicated in Women with a BMI greater than or equal to 30 kg/m(2)
Levonorgestrel/ethinyl estradiol is contraindicated in women with a BMI greater than or equal to 30 kg/m(2). Compared to women with a lower BMI, women with a BMI greater than or equal to 30 kg/m(2) had reduced effectiveness and may have a higher risk for venous thromboembolism events (VTEs)[6].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Ethinyl Estradiol; Levonorgestrel Counseling

A

Inform patient of serious long-term adverse effects of hormone therapy including myocardial infarction, stroke, deep vein thrombosis, pulmonary embolism, dementia, and breast or endometrial cancer [6][19].
Advise patient to report symptoms of pregnancy, including amenorrhea that occurs in 2 or more consecutive cycles, and to discontinue use if pregnancy is confirmed
Oral side effects may include elevated blood pressure, headache, migraines, enlarged or tender breasts, dizziness, mood changes, nausea and pancreatitis [19].
Transdermal side effects may include application site disorders, nausea, headache, dysmenorrhea, and increased weight.
Tell patient to report persistent or prolonged vaginal bleeding.
Instruct patient to report any unexplained partial or complete loss of vision and patient who wears contact lenses to report visual changes or changes in lens tolerance.
Advise patient to use a non-hormonal backup form of contraception for the first 7 days of use.
Counsel patient to take oral tablets at the same time each day.
Instruct patient using transdermal patch to avoid frequent or prolonged water exposure and large amounts of body lotions or oils and to check for partial or complete detachment once daily and also after water exposure.
Tell patient to avoid smoking cigarettes during therapy.
Instruct patient to avoid St. John’s Wort during therapy.
Counsel patient to contact healthcare professional for instructions if a dose is missed and that additional contraception may be required in the event of a missed dose.

57
Q

Ethinyl Estradiol: Norethindrone Class

A

Contraceptive, Estrogen

58
Q

Ethinyl Estradiol: Norethindrone Indication

A

Contraception

59
Q

Ethinyl Estradiol: Norethindrone MoA

A

Combined oral contraceptives suppress gonadotropins to prevent pregnancy. Inhibition of ovulation is the primary mechanism by which pregnancy is prevented. Gonadotropin suppression also changes the cervical mucus, increasing the difficulty of sperm entry into the uterus, and altering the endometrium to reduce the likelihood of implantation

60
Q

Ethinyl Estradiol: Norethindrone Pregnancy Category

A

Contraindicated

61
Q

Ethinyl Estradiol: Norethindrone Contraindication

A

A)Blood pressure 160 mmHg or greater systolic or 100 mgHg or greater, persistent
B) Carcinoma of the breast, known or suspected, or personal history of breast cancer
C) Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia
D) Cerebral vascular or coronary artery disease, current or history
E) Cholestatic jaundice of pregnancy or jaundice with prior pill use
F) Concomitant hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir
G) Deep vein thrombophlebitis or thromboembolic disorders, past history
H) Diabetes with vascular involvement
I) Genital bleeding, undiagnosed abnormal
J) Headaches with focal neurological symptoms
K) Hepatic adenomas or carcinomas
L) Hepatocellular disease with abnormal liver function, acute or chronic
M) Hypersensitivity to any component of the product
N) Hypertension, uncontrolled
O) Major surgery with prolonged immobilization
P) Pregnancy, known or suspected
Q) Thrombophlebitis, thromboembolic disorders, or known thrombophilic conditions
R) Valvular heart disease with complications

62
Q

Ethinyl Estradiol: Norethindrone Black Box Warning

A

1) Oral (Tablet)
Modicon(R), Ortho-Novum(R):
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, combination oral contraceptives, including norethindrone/ethinyl estradiol, should not be used by women who are over 35 years of age and smoke.

Ovcon 35(R):
Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with the extent of smoking (in epidemiologic studies, 15 or more cigarettes per day was associated with a significantly increased risk) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

63
Q

Ethinyl Estradiol: Norethindrone Counseling Points

A

Advise patient to practice safe sex. Drug does not prevent disease transmission.
Discuss potential long-term adverse effects of hormone therapy including myocardial infarction, stroke, thrombophlebitis, dementia, pulmonary embolism, or breast cancer.
This drug may cause chloasma, change in weight, bloating, nausea, stomach cramps, vomiting, migraine, depression, amenorrhea, breakthrough bleeding, breast tenderness or swelling, or nipple discharge.
Tell patient to report persistent/recurrent abnormal vaginal bleeding.
Patients should report any unexplained partial or complete loss of vision. In addition, patients who wear contact lenses should report visual changes or changes in lens tolerance.
This drug should be taken every day, at the same time each day with not more than 24 h between doses.
Advise patient to use a non-hormonal backup form of contraception for the first 7 days if a Sunday-start regimen is initiated.
Patients should not smoke during therapy, as this increases the risk of serious cardiovascular side effects.
Review with the patient the procedure for handling missed doses. It is very important that the patient follow carefully missed-dose instructions for the particular brand or formulation prescribed in order to prevent pregnancy. In many cases, this will necessitate the use of a back-up method of contraception until the regular schedule has been reestablished.
If patient is still unsure of what to do in the event of a missed dose, patient should use a back-up form of contraception and contact healthcare professional for instructions.

64
Q

Ethinyl Estradiol: Norgestimate Class

A

Contraceptive, Endocrine-Metabolic Agent

65
Q

Ethinyl Estradiol: Norgestimate Indication

A

Acne - Contraception
Contraception

66
Q

Ethinyl Estradiol: Norgestimate MoA

A

Ethinyl estradiol, an estrogen, and norgestimate, a progestin, are a combination product that reduces the possibility of pregnancy primarily via suppression of ovulation; although, other mechanisms may include changes in cervical mucus that inhibit sperm penetration and in the endometrium that reduce the chances of implantation. The exact mechanism involved in the treatment of acne is not established, but may be related to increase of sex hormone-binding globulin and reduction of free testosterone

67
Q

Ethinyl Estradiol: Norgestimate Pregnancy Category

A

Contraindicated

68
Q

Ethinyl Estradiol: Norgestimate Contraindication

A

A)Arterial or venous thrombotic diseases, patients at high risk
B) Breast cancer or other estrogen-or progestin-sensitive cancer, history of or current
C) Cerebrovascular disease
D) Concomitant hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir
E) Coronary artery disease
F) Diabetes mellitus with vascular disease
G) DVT or pulmonary embolism, history of or current
H) Headaches with focal neurological symptoms
I) Hypercoagulopathies, inherited or acquired
J) Hypertension, uncontrolled
K) Liver disease or liver tumors, benign or malignant
L) Migraine headaches in patients older than 35 years
M) Migraine headaches with aura
N) Pregnancy
O) Smoking, women older than 35 years
P) Thrombogenic valvular or thrombogenic rhythm diseases of the heart (eg, atrial fibrillation or subacute bacterial endocarditis with valvular disease)
Q) Uterine bleeding, undiagnosed abnormal

69
Q

Ethinyl Estradiol: Norgestimate Black Box Warning

A

1) Oral (Tablet)
Cigarette Smoking and Serious Cardiovascular Events
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use.
This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked.
For this reason, combination oral contraceptives are contraindicated in women who are over 35 years of age and smoke

70
Q

Ethinyl Estradiol: Norgestimate Counseling Points

A

Warn patient to report symptoms of venous or arterial thrombosis.
Instruct patient to report symptoms of gallbladder disease or jaundice.
Counsel patient to report any irregularities in vaginal bleeding.
Side effects may include headache, migraine, abdominal pain, flatulence, vaginal infection, genital discharge, breast discharge, breast pain or enlargement, mood disorders, nervousness, chloasma, and weight changes.
Advise patient to take tablet at the same time every day.
Instruct patient that if a single active dose is missed, including vomiting or diarrhea within 3 to 4 hours after the active dose, take the tablet as soon as possible and resume a normal schedule. If more than one active dose is missed, contact a physician for instructions. Use of additional nonhormonal methods of contraception may be necessary.

71
Q

Ferrous Sulfate Class

A

Iron Supplement, Mineral Supplement

72
Q

Ferrous Sulfate Indication

A

Iron deficiency

73
Q

Ferrous Sulfate MoA

A

Ferrous sulphate contains iron and most of the iron in the body is present as haemoglobin. The remainder is present in the storage forms ferritin or hemosiderin, in the reticuloendothelial system or as myoglobin with smaller amounts occurring in haem-containing enzymes or in plasma bound to transferrin

74
Q

Ferrous Sulfate Pregnancy Category

A

None

75
Q

Ferrous Sulfate Contraindicated

A

Specific Indications have not been
1) anemia other than iron-deficiency anemia
2) hemochromatosis
3) hemosiderosis
4) hypersensitivity to iron products

76
Q

Ferrous Sulfate Black Box

A

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately

77
Q

Ferrous Sulfate Counseling Points

A

Works best when taken on an empty stomach. If there is a stomach ache, try with food. Most people feel better after taking it for 1 week. May take up to 4 weeks to feel full effect. Common side effects include feeling or being sick, constipation, and diarrhoea

Do not chew or crush - administer with a full cup of water or juice on an empty stomach. If we miss a dose, take it as soon as you remember. But if it’s close to your next dose, skip it and take it when you are usually suppose to

78
Q

Folic Acid Brand Name

A

FA-8

79
Q

Folic Acid Class

A

Essential B Vitamin

80
Q

Folic Acid Indication

A

Folic acid deficiency

81
Q

Folic Acid MoA

A

Folic acid is required for the conversion of deoxyuridylate to thymidylate, which is a rate-limiting step in DNA synthesis. Folic acid deficiency presents clinically as macrocytic anemia when red blood cells are unable to extrude their nucleus.

82
Q

Folic Acid Pregnancy Category

A

None

83
Q

Folic Acid Contraindication

A

Hypersensitivity

84
Q

Folic Acid Black Box Warning

A

N/A

85
Q

Folic Acid Counseling Points

A

May require several weeks for maximum effect. Avoid alcohol as it inhibits the absorption of folic acid.

86
Q

Levothyroxine Brand Name

A

Synthroid

87
Q

Levothyroxine Class

A

Thyroid supplements

88
Q

Levothyroxine Indication

A
  1. Hypothyroidism
  2. Thyroid-stimulating hormone suppression, pituitary
89
Q

Levothyroxine MoA

A

Levothyroxine sodium is a synthetic thyroid hormone. The endogenous thyroid hormones, T3 and T4, diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins.

90
Q

Levothyroxine Pregnancy Category

A

Compatible

91
Q

Levothyroxine contraindication

A

Hypersensitivity, nontoxic diffuse goiter or nodular thyroid disease, thyrotoxicosis, AMI, treatment of obesity or weight loss, uncorrected adrenal insufficiency; may precipitate acute adrenal crisis

92
Q

Levothyroxine Black Box

A

Not for weight reduction

93
Q

Levothyroxine Counseling points

A

May require 6-8 wk for symptomatic improvement. Avoid abrupt discontinuation. Take on an empty stomach, with water at least 30 min before food. Avoid antacids and iron within 4 h of dose.

94
Q

Methimazole Brand Name

A

Tapazole

95
Q

Methimazole Class

A

Thionamides, Antithyroid Agents

96
Q

Methimazole Indication

A
  1. Hyperthyroidism
  2. Graves disease, Thyrotoxicosis
  3. Patients with toxic multinodular goiter who are poor candidates for surgery or radioactive iodine therapy.
  4. Thyrotoxicosis, Drug-induced
97
Q

Methimazole MoA

A

It is used to treat overactive thyroid (hyperthyroidism). It prevents the thyroid gland from making too much thyroid hormone. It interferes with the step that causes the iodination of tyrosine residues in thyroglobulin, mediated by the enzyme thyroid peroxidase, thus preventing the synthesis of thyroxine (T4) and triiodothyronine(T3)

Methimazole, a thyroid hormone synthesis inhibitor, is used in the treatment of hyperthyroidism. Its actions are similar to propylthiouracil although it does not inactivate the existing thyroxine and triiodothyronine stored in the thyroid or in the blood

98
Q

Methimazole Pregnancy Category

A

Fetal risk cannot be ruled out

99
Q

Methimazole Contraindication

A

Hypersensitivity

100
Q

Methimazole Black Box

A

N/A

101
Q

Methimazole Counseling Points

A

Immediately report any symptoms of agranulocytosis. Prompty report symptoms of vasculitis (e.g. new rash, hematuria, decreased urine output, dyspnea, or hemoptysis). Side effects may include urticaria, nausea, vomitting, epigastric distress, arthralgia, paresthesia, loss of taste, abnormal loss of hair, myalgia, headache, pruritus, drowsiness, neuritis, edema, vertigo, and skin pigmentation. Instruct patient to report symptoms of hepatotoxicity, hypothyroidism, drug fever, a lupus-like syndrome, or insulin autoimmune syndrome

102
Q

Norethindrone Brand Name

A

Errin, Camila, Golivette, Lyza, Nora-BE, Nor-QD, Ortho Micronor

103
Q

Norethindrone Class

A

Contraceptive, Progestin

104
Q

Norethindrone Indication

A
  1. Pregnancy Prevention (oral contraceptive)
  2. Women with secondary amenorrhea (absence of menstral period in women who have previously had a menstrual period who are not pregnant), endometriosis, and irregular menstrual periods cause dby hormonal imbalance
105
Q

Northindrone MoA

A

Norethindrone is a progestin contraceptive that prevents ovulation, inhibits sperm penetration by thickening the cervical mucus, reduces the midcycle luteinizing hormone and follicle-stimulating hormone peaks, delays the movement of ovum through the fallopian tube, and alters the endometrium lining [4]. Norethisterone has progestational action similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle

106
Q

Northindrone Pregnancy Category

A

Contraindicated

107
Q

Northindrone Contraindication

A

Abnormal and diagnosed genital bleeding, acute liver disease, benign or maligant liver tumors. Carcinoma of the breast, hypersensitivitity to any component of the product, pregnancy.

108
Q

Northindrone Black Box Warning

A

N/A

109
Q

Northindrone Counseling Points

A

Side effects include nausea, dizziness, headache, breast, tenderness, or irregular periods. Tell patient to report persistent or recurrent abnormal vaginal bleeding, amenorrhea, or severe abdominal pain. Advise patient to take drug every day, at the same time of day, with no more than 24 hours between doses, including durin bleeding episodes. Avoid smoking during therapy as this increases the risk of heart attack or stroke. Use an alternative non-hormonal or back-up method of contraception while taking St. John’s wort and for 28 days after discontinuing St. John’s wort. If a dose is missed by 3 hours or more, take the missed pill as soon as remembered, then resume normal schedule, and use a backup method (eg, condom and spermicide) for 48 hours

110
Q

Potassium Chloride Brand Name

A

Klor-Con

111
Q

Potassium Class

A

Electrolyte, potassium

112
Q

Potassium Indication

A

Hypokalemia, Hypokalemia, prophylaxis

113
Q

Potassium MoA

A

Potassium is an electrolyte required for maintenance of the excitatory properties of neuromuscular tissues, and the resting membrane potential of cells is related to potassium concentrations, varying directly with the ratio of intracellular to extracellular potassium level.

114
Q

Potassium Pregnancy Category

A

Compatible

115
Q

Potassium Contraindication

A

Hypersensitivity to potassium, acute renal failure, structural, pathologic, or pharmacologic causes that delay tablet passage through the GI tract, hyperkalemia, Addison disease, acute dehydration

116
Q

Potassium Black Box

A

N/A

117
Q

Potassium Counseling Points

A

Take with food. Take the powder, granule, or oral liquid only after mixing in 4 oz of water or juice. Crush or break only specifically designed extended-release formulations. Capsules may be opened, sprinkled on apple sauce, and ingested immediately. Completely dissolve effervescent tablets in liquid and sip slowly over a 5-10 min period.

118
Q

Progesterone Brand Name

A

Prometrium

119
Q

Progesterone Class

A

Progestin Hormone

120
Q

Progesterone Indication

A
  1. Prevention of estrogen-induced endmetrial hyperplasia
  2. Secondary physiologic amenorrhea
  3. Assisted reproduction for infertile women
121
Q

Progesterone MoA

A

Progesterone transforms proliferative endometrium into secretory endometrium. Parenterally administered progesterone inhibits gonadotropin production, which in turn prevents follicular maturation and ovulation.

122
Q

Progesterone Pregnancy Categories

A

Weight risks and benefits

123
Q

Progesterone Contraindication

A

Abnormal vaginal bleeding, history of estrogen- or progesterone-dependent neoplasia, active or history of DVT or PE, known or suspected pregnancy (oral only)

124
Q

Progesterone Black Box Warning

A

Cardiovascular disorders, breast cancer, dementia risk, risk versus benefits

125
Q

Progesterone Counseling Points

A

Menstrual bleeding should occur 3-7 d after last dose. Report if menstruation does not occur within 7 d after last dose. For vaginal formulation, avoid using other vaginal drugs within 6 h before or 6 h after using progesterone.

126
Q

Testosterone Brand Name

A

AndroGel

127
Q

Testosterone Class

A

Androgen, C-III

128
Q

Testosterone Indication

A

Hypogonadism

129
Q

Testosterone MoA

A

Testosterone is an endogenous androgen. Androgens are responsible for normal growth and development of male sex organs. Testosterone is involved in the growth and maturation of the prostate, seminal vesicles, penis, and scrotum; development of male hair distribution; laryngeal enlargement; vocal cord thickening; alterations in body musculature; and fat distribution.

130
Q

Testosterone Pregnancy Category

A

Contraindicated

131
Q

Testosterone Contraindication

A

Hypersensitivity to testosterone; men with breast or prostate cancer; women who are pregnant, who may become pregnant, or who are breast-feeding

132
Q

Testosterone Black Box Warning

A

Secondary Exposire

133
Q

Testosterone Counseling Points

A

Gel to be applied to clean, dry, intact skin of the shoulders and upper arms and/or abdomen but should not be applied to genitals. Gel should be allowed to dry well; swimming and showering should be avoided for 5-6 h after application. Patients should keep application site covered, as direct skin contact can transfer drug to others. Virilization has been reported in children who were secondarily exposed to testosterone gel (coming in contact with bare skin around gel application site). Male patients should report too frequent or persistent erections. Female sexual partners of patients using drug should report male-like changes. Do not use higher doses than you have been prescribed, or combine with other anabolic steroids, serious adverse effects can occur. Seek medical attention if chest pain, shortness of breath, signs of stroke, or behavioral changes.

134
Q

Thyroid Brand Name

A

Armour Thyroid

135
Q

Thyroid Class

A

Thyroid supplements

136
Q

Thyroid Indication

A

Hypothyroidism

137
Q

Thyroid MoA

A

Thyroid hormone is a naturally derived thyroid replacement containing both levothyroxine (T4) and liothyronine (T3). The endogenous thyroid hormones, T3 and T4, diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins.

138
Q

Thyroid Pregnancy Category

A

Compatible

139
Q

Thyroid Contraindication

A

Hypersensitivity to thyroid, nontoxic diffuse goiter or nodular thyroid disease, thyrotoxicosis, AMI, treatment of obesity or weight loss, uncorrected adrenal insufficiency; may precipitate acute adrenal crisis

140
Q

Thyroid Black Box Warning

A

Ineffective and potentially toxic when used for weight loss

141
Q

Thyroid Key Counseling Points

A

May require 6-8 wk before symptoms improve. Do not stop using this medicine suddenly without asking your doctor; may need to slowly decrease dose before stopping it completely. Take on an empty stomach, with water.